Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ziprasidone in pediatric Bipolar I Disorder
NCT01117220Phase 3Withdrawn
- Sponsor
- Viatris
- Start
- Jun 2010
- Primary completion
- Apr 2011
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in bipolar I disorder comparing Ziprasidone with Placebo (2 arms). Primary endpoint: Young Mania Rating Scale at 4 weeks. Planned start Jun 2010; status: withdrawn.
02
Drugs
ziprasidone
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on NCT01117220.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01117220.